678
Total Claims
$844K
Drug Cost
182
Beneficiaries
$4,639
Cost/Patient
Peer Comparison vs. 8,541 Hematology-Oncology providers
+20%
Opioid rate vs peers
7.5% vs 6.3% avg
-66%
Cost per patient vs peers
$4,639 vs $14K avg
+6%
Brand preference vs peers
15.5% vs 14.6% avg
Opioid Prescribing
7.5%
Opioid Rate
51
Opioid Claims
$4,425
Opioid Cost
23.5%
Long-Acting Rate
Brand vs Generic
85% generic
Brand: 105 claims · $707K
Generic: 573 claims · $137K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Osimertinib Mesylate | 11 | $245K |
| Abiraterone Acetate | 15 | $104K |
| Apixaban | 15 | $8,703 |
| Anastrozole | 36 | $1,043 |
| Ondansetron | 42 | $727 |
| Prochlorperazine Maleate | 47 | $592 |
| Letrozole | 21 | $581 |
| Gabapentin | 48 | $513 |
| Omeprazole | 16 | $477 |
| Dexamethasone | 47 | $476 |
| Bicalutamide | 21 | $435 |
| Oxycodone Hcl | 33 | $252 |
| Triamcinolone Acetonide | 13 | $248 |
| Levothyroxine Sodium | 31 | $193 |
| Sulfamethoxazole/Trimethoprim | 15 | $131 |
Prescribing Profile
18
Unique Drugs
$8,703
Patient Profile
74
Avg Age
53%
Female
2.16
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About